Cargando…
Single Center Experience With Hyperthermic Intraperitoneal Chemotherapy
PURPOSE: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been proposed for controlling peritoneal seeding metastasis in some kinds of cancers, including those of colorectal origin, but their safety and oncological benefits are subjects of debate. We present our...
Autores principales: | Kim, Woo Ram, Hur, Hyuk, Min, Byung Soh, Baik, Seung Hyuk, Lee, Kang Young, Kim, Nam Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Coloproctology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346776/ https://www.ncbi.nlm.nih.gov/pubmed/28289659 http://dx.doi.org/10.3393/ac.2017.33.1.16 |
Ejemplares similares
-
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colorectal cancer with peritoneal carcinomatosis: Clinical outcomes at 2 tertiary referral centers in Korea
por: Park, Eun Jung, et al.
Publicado: (2017) -
Benign multicystic mesothelioma of appendiceal origin treated by hyperthermic intraperitoneal chemotherapy: A case report
por: Lee, Suk Jun, et al.
Publicado: (2022) -
Single-center Experience of 24 Cases of Tailgut Cyst
por: Sakr, Ahmad, et al.
Publicado: (2019) -
Impact of Mitomycin-C-Induced Neutropenia after Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery in Colorectal Cancer Patients with Peritoneal Carcinomatosis
por: Lee, Suk Jun, et al.
Publicado: (2021) -
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Riggs, McKayla J., et al.
Publicado: (2020)